<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; GB</title>
	<atom:link href="http://www.stockbloghub.com/tag/gb/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Wed, 23 May 2012 20:22:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(VZ) Verizon Communications Unveils Home Broadband</title>
		<link>http://www.stockbloghub.com/2012/03/09/vz-verizon-communications-unveils-home-broadband/94678</link>
		<comments>http://www.stockbloghub.com/2012/03/09/vz-verizon-communications-unveils-home-broadband/94678#comments</comments>
		<pubDate>Fri, 09 Mar 2012 22:34:09 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[Telecom Services - Domestic]]></category>
		<category><![CDATA[AT&T Inc.]]></category>
		<category><![CDATA[Clearwire Corporation]]></category>
		<category><![CDATA[CLWR]]></category>
		<category><![CDATA[GB]]></category>
		<category><![CDATA[Greatbatch Inc]]></category>
		<category><![CDATA[S]]></category>
		<category><![CDATA[Sprint Nextel Corporation]]></category>
		<category><![CDATA[T]]></category>
		<category><![CDATA[Verizon Communications Inc.]]></category>
		<category><![CDATA[VZ]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=94678</guid>
		<description><![CDATA[The largest U.S. mobile service provider Verizon Communications Inc. (VZ) launched an in-home wireless broadband service –– HomeFusion Broadband –– based on Long Term Evolution (LTE) technology. Verizon introduced this service in rural and remote homes, which do not have access to DSL or cables. The service will be available initially in Birmingham, Alabama, Dallas and Nashville, Tennessee later this month. The company will charge $59.99 per month for 10 gigabytes (GB) of data and an initial fee of $199.99 for installing the antenna device either on an outside wall or at the roof. Home Fusion provides download speed of 5 to 12 megabits per second and 2 to 5 megabits for upload. Verizon is further seeking the deployment of 4G services to rural areas using tower and back-haul assets ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/03/09/vz-verizon-communications-unveils-home-broadband/94678/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GB) Greatbatch Buying NeuroNexus</title>
		<link>http://www.stockbloghub.com/2012/02/23/gb-greatbatch-buying-neuronexus/92142</link>
		<comments>http://www.stockbloghub.com/2012/02/23/gb-greatbatch-buying-neuronexus/92142#comments</comments>
		<pubDate>Thu, 23 Feb 2012 19:36:28 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[GB]]></category>
		<category><![CDATA[Greatbatch Inc]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=92142</guid>
		<description><![CDATA[Medical technology company Greatbatch (GB) is acquiring Michigan-based implantable medical device design firm NeuroNexus Technologies for roughly $12 million. The deal includes assumption of debt and future considerations (undisclosed). NeuroNexus, founded in 2004, specializes in high-value neural interface technology, components and systems for neuroscience and clinical markets. The entity possesses a vast portfolio of intellectual property, core technologies and capabilities to facilitate the development of innovative neural interface devices across a broad range of functions including neuromodulation, optical stimulation and targeted drug delivery applications. The acquisition is expected to boost Greatbatch’s foothold across cardiovascular and neuromodulation markets. The pooling of NeuroNexus’ technologies and Greatbatch’s capabilities will enable the combined entity to provide new world-class research products and systems to neuroscientists across the globe. Greatbatch expects the acquisition to be non-dilutive ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/02/23/gb-greatbatch-buying-neuronexus/92142/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(S) Sprint Announces Holiday Discounts</title>
		<link>http://www.stockbloghub.com/2011/11/22/s-sprint-announces-holiday-discounts/87054</link>
		<comments>http://www.stockbloghub.com/2011/11/22/s-sprint-announces-holiday-discounts/87054#comments</comments>
		<pubDate>Tue, 22 Nov 2011 17:33:30 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[Wireless Communications]]></category>
		<category><![CDATA[AT&T Inc.]]></category>
		<category><![CDATA[GB]]></category>
		<category><![CDATA[Greatbatch Inc]]></category>
		<category><![CDATA[S]]></category>
		<category><![CDATA[Sprint Nextel Corporation]]></category>
		<category><![CDATA[T]]></category>
		<category><![CDATA[Verizon Communications Inc.]]></category>
		<category><![CDATA[VZ]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=87054</guid>
		<description><![CDATA[Looking ahead at the Christmas and holiday season, Sprint (S) has announced discounted offering on wireless Broadband services. The company will now charge $50 a month for 6 gigabytes (GB) compared to its previous offer (launched in November 1) of $60 a month for 5 GB. The discounted offer does not cover smartphone users but counts data downloads on tablets, mobile hotspots and laptops. The strategic decision to cut wireless data prices will help Sprint garner market traction as well as compete head to head with market Czars like AT&#38;T (T) and Verizon (VZ) as both offer $50 per month for 5 GB.  Additionally, Sprint&#8217;s new offer is aimed at wooing more customers and driving revenues during the peek holiday season. Sprint will also charge less for using extensive data ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/22/s-sprint-announces-holiday-discounts/87054/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GB) Greatbatch Analyst Raises Shares to Outperform</title>
		<link>http://www.stockbloghub.com/2011/11/06/gb-greatbatch-analyst-raises-shares-to-outperform/86509</link>
		<comments>http://www.stockbloghub.com/2011/11/06/gb-greatbatch-analyst-raises-shares-to-outperform/86509#comments</comments>
		<pubDate>Sun, 06 Nov 2011 20:47:44 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[GB]]></category>
		<category><![CDATA[Greatbatch Inc]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=86509</guid>
		<description><![CDATA[We upgrade our recommendation on Greatbatch (GB) to Outperform following its impressive third-quarter 2011 results. Adjusted earnings of 41 cents for the quarter outstripped the Zacks Consensus Estimate of 34 cents. Profit surged 17% year over year. Sales rose 3% year over year to $131.7 million, matching the Zacks Consensus Estimate. Revenues and profit were boosted by double-digit growth across the company’s Orthopedic and Vascular franchises, which offset the decline in the Electrochem unit. The company backed its revenue and earnings forecast for the full year. Greatbatch is a leading producer and supplier of batteries, capacitors and components used in implantable medical devices. The company’s top customers include Boston Scientific (BSX), Johnson &#38; Johnson (JNJ), Medtronic (MDT) and St. Jude (STJ). Greatbatch has been acquiring complementary businesses over the last ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/06/gb-greatbatch-analyst-raises-shares-to-outperform/86509/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GB) Greatbatch Third Quarter 2011 Earnings Helped By Medical Business</title>
		<link>http://www.stockbloghub.com/2011/11/02/gb-greatbatch-third-quarter-2011-earnings-helped-by-medical-business/86281</link>
		<comments>http://www.stockbloghub.com/2011/11/02/gb-greatbatch-third-quarter-2011-earnings-helped-by-medical-business/86281#comments</comments>
		<pubDate>Wed, 02 Nov 2011 21:02:45 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[GB]]></category>
		<category><![CDATA[Greatbatch Inc]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=86281</guid>
		<description><![CDATA[Greatbatch’s (GB) third-quarter fiscal 2011 adjusted (excluding one-time items) earnings per share of 41 cents outpaced both the Zacks Consensus Estimate and the year-ago adjusted earnings of 34 cents. Profit (as reported) soared 17% year over year to roughly $7 million (or 30 cents a share) owing to healthy sales from the New York-based company’s Orthopedic and Vascular businesses, supported by lower interest expense and tax. Revenues Revenues rose 3% year over year to $131.7 million, in line with the Zacks Consensus Estimate. Double-digit growth across the Orthopedic and Vascular franchises masked a decline in the Electrochem division. Foreign currency movements contributed $2 million to orthopedic revenues in the quarter. Segment Review Sales from the larger Greatbatch Medical division rose 6% year over year to $113.3 million as the company ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/02/gb-greatbatch-third-quarter-2011-earnings-helped-by-medical-business/86281/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GB) Greatbatch Analyst Reaffirms Shares at Neutral</title>
		<link>http://www.stockbloghub.com/2011/08/09/gb-greatbatch-analyst-reaffirms-shares-at-neutral/80927</link>
		<comments>http://www.stockbloghub.com/2011/08/09/gb-greatbatch-analyst-reaffirms-shares-at-neutral/80927#comments</comments>
		<pubDate>Tue, 09 Aug 2011 19:25:15 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[GB]]></category>
		<category><![CDATA[Greatbatch Inc]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=80927</guid>
		<description><![CDATA[We reiterate our Neutral recommendation for Greatbatch Inc. (GB). Second-quarter fiscal 2011 earnings per share of 43 cents met the Zacks Consensus Estimate. Revenues rose 4% year over year to $146.5 million, topping the Zacks Consensus Estimate of $141 million. Sales were boosted by solid double-digit growth at the company’s Orthopedic franchise backed by favorable foreign exchange translation, which offset declines across other businesses. Greatbatch lifted its revenue and earnings forecast for the full year. Orthopedic revenues surged 24% in the quarter, fueled by customer product launches, market share gains as well as favorable foreign currency impact. Vascular Access sales fell 2% while CRM/Neuromodulation revenues edged down 1%, hurt by sustained pricing pressure and sluggishness in the CRM market. Revenues from Greatbatch’s Electrochem segment dipped 2% in the quarter. Greatbatch ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/08/09/gb-greatbatch-analyst-reaffirms-shares-at-neutral/80927/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CSCO) Mobile Operators Revise Data Plans</title>
		<link>http://www.stockbloghub.com/2011/06/25/csco-mobile-operators-revise-data-plans/77476</link>
		<comments>http://www.stockbloghub.com/2011/06/25/csco-mobile-operators-revise-data-plans/77476#comments</comments>
		<pubDate>Sat, 25 Jun 2011 15:32:48 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Networking & Communication Devices]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[AT&T Inc.]]></category>
		<category><![CDATA[Cisco Systems]]></category>
		<category><![CDATA[CSCO]]></category>
		<category><![CDATA[GB]]></category>
		<category><![CDATA[Greatbatch Inc]]></category>
		<category><![CDATA[LEAP]]></category>
		<category><![CDATA[Leap Wireless International Inc]]></category>
		<category><![CDATA[MetroPCS Communications Inc.]]></category>
		<category><![CDATA[PCS]]></category>
		<category><![CDATA[S]]></category>
		<category><![CDATA[Sprint Nextel Corporation]]></category>
		<category><![CDATA[T]]></category>
		<category><![CDATA[Verizon Communications Inc.]]></category>
		<category><![CDATA[VZ]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77476</guid>
		<description><![CDATA[The demand for smartphones is currently on the rise, leading to a growing requirement for wireless data services. Data usage has more than doubled over the last three years. Cisco Systems Inc. (CSCO) estimated that mobile traffic would grow 26 folds and total mobile video traffic will expand to 197 million gigabytes (GB) over the next four years. Given the surge in data traffic demand, mobile operators are revising their monthly data plans to attract more subscribers. Accordingly, the operators are switching to tiered-data pricing plans from the unlimited data plans. As per market rumors, the largest U.S. mobile service provider Verizon Communications (VZ) will release its new monthly data plans next month. The company is expected to offer three tiered-data plans without any tethering beginning July 7. Verizon would ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/25/csco-mobile-operators-revise-data-plans/77476/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(T) AT&amp;T Wireless Eliminates Unlimited Data Plans</title>
		<link>http://www.stockbloghub.com/2010/06/07/t-att-wireless-eliminates-unlimited-data-plans-2/39274</link>
		<comments>http://www.stockbloghub.com/2010/06/07/t-att-wireless-eliminates-unlimited-data-plans-2/39274#comments</comments>
		<pubDate>Mon, 07 Jun 2010 22:05:19 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[Telecom Services - Domestic]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[AT&T Inc.]]></category>
		<category><![CDATA[Deutsche Telekom AG]]></category>
		<category><![CDATA[DT]]></category>
		<category><![CDATA[GB]]></category>
		<category><![CDATA[Greatbatch Inc]]></category>
		<category><![CDATA[S]]></category>
		<category><![CDATA[Sprint Nextel Corporation]]></category>
		<category><![CDATA[T]]></category>
		<category><![CDATA[Verizon Communications Inc.]]></category>
		<category><![CDATA[VZ]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=39274</guid>
		<description><![CDATA[In a major move, AT&#38;T (T) has introduced new data plans for its smartphone and iPad users, thereby bringing its existing unlimited data plans to an end. The new price plans, which replace AT&#38;T’s current $30 monthly unlimited wireless data plan, however, do not affect the carrier’s existing subscribers who can continue with the benefits of unlimited usage. Nevertheless, existing smartphone users have the option to switch to the new plans without extending their service contracts. AT&#38;T’s announcement comes ahead of the introduction (likely June 7) of the next-generation iPhone by Apple (AAPL). Ma Bell’s new strategy indicates a paradigm shift in wireless tariff structure as the industry is again becoming more and more inclined towards a tiered (or metered) pricing system, replacing the existing flat-monthly unlimited plans. Carriers abandoned ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/06/07/t-att-wireless-eliminates-unlimited-data-plans-2/39274/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(T) AT&amp;T Wireless Eliminates Unlimited Data Plans</title>
		<link>http://www.stockbloghub.com/2010/06/06/t-att-wireless-eliminates-unlimited-data-plans/39310</link>
		<comments>http://www.stockbloghub.com/2010/06/06/t-att-wireless-eliminates-unlimited-data-plans/39310#comments</comments>
		<pubDate>Mon, 07 Jun 2010 05:37:30 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[Telecom Services - Domestic]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[AT&T Inc.]]></category>
		<category><![CDATA[Deutsche Telekom AG]]></category>
		<category><![CDATA[DT]]></category>
		<category><![CDATA[GB]]></category>
		<category><![CDATA[Greatbatch Inc]]></category>
		<category><![CDATA[S]]></category>
		<category><![CDATA[Sprint Nextel Corporation]]></category>
		<category><![CDATA[T]]></category>
		<category><![CDATA[Verizon Communications Inc.]]></category>
		<category><![CDATA[VZ]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=39310</guid>
		<description><![CDATA[In a major move, AT&#38;T (T) has introduced new data plans for its smartphone and iPad users, thereby bringing its existing unlimited data plans to an end. The new price plans, which replace AT&#38;T’s current $30 monthly unlimited wireless data plan, however, do not affect the carrier’s existing subscribers who can continue with the benefits of unlimited usage. Nevertheless, existing smartphone users have the option to switch to the new plans without extending their service contracts. AT&#38;T’s announcement comes ahead of the introduction (likely June 7) of the next-generation iPhone by Apple (AAPL). Ma Bell’s new strategy indicates a paradigm shift in wireless tariff structure as the industry is again becoming more and more inclined towards a tiered (or metered) pricing system, replacing the existing flat-monthly unlimited plans. Carriers abandoned ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/06/06/t-att-wireless-eliminates-unlimited-data-plans/39310/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GB) Greatbatch Incorporated &#8211; Bear of the Day</title>
		<link>http://www.stockbloghub.com/2010/03/29/gb-greatbatch-incorporated-bear-of-the-day-3/32104</link>
		<comments>http://www.stockbloghub.com/2010/03/29/gb-greatbatch-incorporated-bear-of-the-day-3/32104#comments</comments>
		<pubDate>Mon, 29 Mar 2010 16:54:51 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[GB]]></category>
		<category><![CDATA[Greatbatch Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=32104</guid>
		<description><![CDATA[Greatbatch (GB) is a leading producer and supplier of batteries, capacitors and components used in implantable medical devices. The company has been acquiring several businesses over the last few years to revive top-line growth, which has been declining over the past few quarters. Total revenues in the fourth quarter declined 14% year over year. The decline was broad-based across all sub-segments. We continue to rate the stock an Underperform with a target price of $18. This is based on a P/E of 10.9x our fiscal 2010 EPS estimate. Zacks Investment Research]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/29/gb-greatbatch-incorporated-bear-of-the-day-3/32104/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GB) Greatbatch Analyst Maintain Ratings at Underperform</title>
		<link>http://www.stockbloghub.com/2010/03/25/gb-greatbatch-analyst-maintain-ratings-at-underperform/31750</link>
		<comments>http://www.stockbloghub.com/2010/03/25/gb-greatbatch-analyst-maintain-ratings-at-underperform/31750#comments</comments>
		<pubDate>Fri, 26 Mar 2010 00:42:01 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[GB]]></category>
		<category><![CDATA[Greatbatch Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=31750</guid>
		<description><![CDATA[We recently reiterated our ‘Underperform’ rating on Greatbatch, Inc. (GB) with a target price of $18 based on a P/E of 10.9x our fiscal 2010 EPS estimate of $1.65. The company reported disappointing fourth quarter and fiscal 2009 results with top-line erosion witnessed in both these periods and across all business segments. Total revenue in the fourth quarter declined 14% year over year to $125.8 million. Greatbatch Medical revenue declined 14% year over year to $108.8 million. In this segment, CRM/Neuromodulation, Orthopedic and Vascular Access revenue declined 5%, 29% and 32% year over year to $76 million, $25.2 million and $7.6 million, respectively. CRM/Neuromodulation revenue declined due to lower sales of Greatbatch batteries. Orthopedic revenue declined as a result of a weak economic scenario that prompted patients to defer their ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/25/gb-greatbatch-analyst-maintain-ratings-at-underperform/31750/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GB) Greatbatch Receives FDA Approval</title>
		<link>http://www.stockbloghub.com/2010/03/19/gb-greatbatch-receives-fda-approval/31287</link>
		<comments>http://www.stockbloghub.com/2010/03/19/gb-greatbatch-receives-fda-approval/31287#comments</comments>
		<pubDate>Fri, 19 Mar 2010 22:20:21 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[GB]]></category>
		<category><![CDATA[Greatbatch Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=31287</guid>
		<description><![CDATA[Greatbatch Inc. (GB) recently received the U.S. Food and Drug Administration (FDA) 510 (k) approval to market its next generation valved peelable introducer, OptiSeal, in the United States. The OptiSeal valved peelable introducer is used in the delivery of leads and catheters into the venous system. The product has earlier received marketing clearance in Canada and Europe. Greatbatch Medical develops OptiSeal in collaboration with its various original equipment manufacturer (OEM) customers. The company is in the process of setting up a distribution agreement with OEMs. Per the agreement, Greatbatch Medical will manufacture OptiSeal which will be distributed globally by the company’s OEM customers. Greatbatch expects to finalize the distribution agreement by the second half of 2010. Greatbatch reported disappointing fourth quarter and fiscal 2009 results. Total revenue in the quarter ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/19/gb-greatbatch-receives-fda-approval/31287/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GB) Greatbatch&#8217;s Quarterly Report Beats Expectations</title>
		<link>http://www.stockbloghub.com/2010/03/03/gb-greatbatchs-quarterly-report-beats-expectations/29475</link>
		<comments>http://www.stockbloghub.com/2010/03/03/gb-greatbatchs-quarterly-report-beats-expectations/29475#comments</comments>
		<pubDate>Wed, 03 Mar 2010 23:27:51 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[GB]]></category>
		<category><![CDATA[Greatbatch Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=29475</guid>
		<description><![CDATA[Greatbatch, Inc. (GB) reported fourth quarter and fiscal 2009 results. The company’s fourth-quarter earnings per share of 40 cents beat the Zacks Consensus Estimate of 34 cents. However, earnings per share in the year-ago quarter was 50 cents. For fiscal 2009, earnings per share of $1.52 was ahead of last year’s profit of $1.40. Quarterly results Total revenue in the fourth quarter declined 14% year over year to $125.8 million. Greatbatch Medical revenue declined 14% year over year to $108.8 million. The decline was broad-based across all the sub-segments. CRM/Neuromodulation, Orthopedic and Vascular Access revenue declined 5%, 29% and 32% year over year to $76 million, $25.2 million and $7.6 million, respectively. CRM/Neuromodulation revenue declined due to lower sales of Greatbatch batteries. Orthopedic revenue declined as a result of a ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/03/gb-greatbatchs-quarterly-report-beats-expectations/29475/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GB) Greatbatch, Incorporated &#8211; Bear of the Day</title>
		<link>http://www.stockbloghub.com/2009/12/16/gb-greatbatch-incorporated-bear-of-the-day-2/22961</link>
		<comments>http://www.stockbloghub.com/2009/12/16/gb-greatbatch-incorporated-bear-of-the-day-2/22961#comments</comments>
		<pubDate>Wed, 16 Dec 2009 17:23:07 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[GB]]></category>
		<category><![CDATA[Greatbatch Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=22961</guid>
		<description><![CDATA[The flurry of acquisition activities in the past few years have expanded Greatbatch&#8216;s (GB) customer base, particularly in orthopedics, and moved its product portfolio into higher growth segments. The company&#8217;s move into areas beyond original equipment manufacturing should increase future operating margins. However, the company reported disappointing third quarter fiscal 2009 results. Earnings per share were 32 cents, considerably lower than the Zacks Consensus Estimate of 38 cents and the year-ago earnings of 43 cents. The company also witnessed erosion in its top-line. In light of its disappointing performance, we downgrade the stock to Underperform with a target price of $17. Zacks Investment Research]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/16/gb-greatbatch-incorporated-bear-of-the-day-2/22961/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GB) Greatbatch, Incorporated &#8211; Bear of the Day</title>
		<link>http://www.stockbloghub.com/2009/12/10/gb-greatbatch-incorporated-bear-of-the-day/22450</link>
		<comments>http://www.stockbloghub.com/2009/12/10/gb-greatbatch-incorporated-bear-of-the-day/22450#comments</comments>
		<pubDate>Thu, 10 Dec 2009 21:57:09 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[GB]]></category>
		<category><![CDATA[Greatbatch Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=22450</guid>
		<description><![CDATA[The flurry of acquisition activities in the past few years have expanded Greatbatch&#8216;s (GB) customer base, particularly in orthopedics, and moved its product portfolio into higher growth segments. However, the company reported disappointing third quarter fiscal 2009 results. Earnings per share were 32 cents, considerably lower than the Zacks Consensus Estimate of 38 cents and the year-ago earnings of 43 cents. The company also witnessed erosion in its top-line. In light of its disappointing performance, we downgrade the stock to Underperform with a target price of $17. Zacks Investment Research]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/10/gb-greatbatch-incorporated-bear-of-the-day/22450/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GB) Greatbatch Inc&#8217;s Earnings Results Disappoint</title>
		<link>http://www.stockbloghub.com/2009/11/09/gb-greatbatch-incs-earnings-results-disappoint/20040</link>
		<comments>http://www.stockbloghub.com/2009/11/09/gb-greatbatch-incs-earnings-results-disappoint/20040#comments</comments>
		<pubDate>Mon, 09 Nov 2009 23:31:38 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[GB]]></category>
		<category><![CDATA[Greatbatch Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=20040</guid>
		<description><![CDATA[Greatbatch, Inc. (GB) reported third quarter fiscal 2009 earnings per share of 32 cents, lower than the Zacks Consensus Estimate of 38 cents and the year-ago earnings of 44 cents. Sales Total sales in the reported quarter declined 11% year over year to $121.5 million. Excluding CRM/Neuromodulation, negative sales growth was witnessed across all business segments. CRM/Neuromodulation revenues increased 5% year over year to $74.1 million. Growth can be attributed to higher demand for medical batteries due to increased market growth of these products. This was partly offset by lower capacitor sales as a result of inventory adjustments made by Original Equipment Manufacturer (OEM) customers during the quarter. Orthopaedic revenues declined 39% year over year to $23.2 million. The decline was due to lower spending on elective procedures and the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/09/gb-greatbatch-incs-earnings-results-disappoint/20040/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

